Gray Area: Why New York's Primary Care System Is Failing Older Adults With HIV

When Margaret, a 62-year-old retired school administrator from the Bronx, began experiencing persistent fatigue, recurring infections, and unexplained weight loss in the spring of 2022, her internist attributed the symptoms to menopause-related complications and the natural toll of aging. It was not until a hospitalization eighteen months later—prompted by a severe bout of pneumonia—that a physician finally ordered an HIV test. The result was positive. The diagnosis, her infectious disease specialist later told her, was at least two years overdue.

Margaret's story is not an outlier. Across New York City, a quiet but consequential pattern is unfolding inside primary care offices, community health centers, and geriatric clinics: older adults are arriving with textbook HIV symptoms and leaving without a test. They are being counseled about cholesterol and colonoscopies while the virus reshaping their immune systems goes undetected. And when a diagnosis does finally arrive, it frequently comes late—at a stage when treatment must work harder to undo damage that earlier intervention could have prevented.

A Population the Prevention Narrative Left Behind

For much of the past decade, HIV prevention messaging in New York City has rightly prioritized younger populations, communities of color, and LGBTQ+ New Yorkers who face disproportionate risk. That focus has yielded meaningful progress. But it has also produced an unintended consequence: a widespread clinical assumption that HIV is, at its core, a young person's disease.

The numbers complicate that assumption significantly. According to data from the New York City Department of Health and Mental Hygiene, adults over 50 account for more than half of all people living with HIV in the city. Of new diagnoses citywide, a substantial and growing proportion occur in people aged 50 and older—many of whom had no prior HIV testing in the years before their diagnosis. Nationally, the Centers for Disease Control and Prevention estimates that one in six new HIV diagnoses occurs in adults over 50, a figure that has remained stubbornly consistent for more than a decade.

These are not people who slipped through a prevention system designed for them. These are people for whom that system was never fully designed at all.

The Clinical Blind Spot

Physicians who specialize in HIV care are candid about what they observe in referrals from primary care. Symptoms that would prompt immediate HIV screening in a 28-year-old patient—unexplained immunosuppression, recurring oral thrush, significant unintentional weight loss—are routinely attributed in older patients to diabetes complications, autoimmune conditions, or the cumulative effects of aging itself.

This is not simply a matter of individual physician negligence. It reflects a structural gap in how medical training frames HIV risk. Many primary care providers who completed their education before the era of widespread HIV treatment normalization carry deeply embedded associations between HIV and specific demographic profiles. When an older, heterosexual patient who has been with the same partner for twenty years presents with fatigue, HIV testing does not surface as a clinical reflex.

The CDC's current guidelines recommend routine HIV screening for all adults aged 13 to 64 as part of standard care—and targeted testing for those over 64 who exhibit risk factors. In practice, implementation of these guidelines is inconsistent at best. A 2021 study published in the Journal of the American Geriatrics Society found that physicians were significantly less likely to discuss HIV testing with patients over 60, even when those patients presented with clinical indicators that warranted it.

Stigma With a Generational Signature

The problem is not located solely in the examining room. Older adults themselves—shaped by the devastating and highly stigmatized early years of the AIDS crisis—often carry profound reluctance to raise the subject of HIV with their doctors. For many in this generation, an HIV diagnosis was synonymous with death, with social exile, and with the exposure of sexual or drug-use histories they have spent decades concealing.

For older Black and Latino New Yorkers, that stigma is frequently compounded by deeply held community norms around sexual privacy, masculinity, and shame. For older women of any background, the persistent cultural assumption that HIV is not their concern—that it belongs to gay men or intravenous drug users—can make self-advocacy feel both unnecessary and fraught.

The result is a mutual silence: physicians who do not ask and patients who do not volunteer. In that silence, the virus advances.

The Compounding Challenges of Late Diagnosis

A late HIV diagnosis in an older adult carries consequences that extend well beyond the immediate clinical picture. The immune system of a 60-year-old does not reconstitute after antiretroviral therapy with the same resilience as that of a 30-year-old. Older patients who begin treatment with very low CD4 counts face a longer and more uncertain road to viral suppression and immune recovery.

Additionally, managing HIV in an aging body requires navigating a complex web of drug interactions. Many older adults are already taking multiple medications for conditions such as hypertension, diabetes, or cardiovascular disease. Antiretroviral regimens must be carefully selected to avoid interactions that can reduce efficacy or increase toxicity—a level of pharmacological complexity that demands HIV expertise many primary care physicians simply do not have.

There is also the matter of mental health. Receiving an HIV diagnosis at 60 or 70 carries its own specific psychological weight. It can upend a person's sense of their past, their relationships, and their remaining years. Yet geriatric mental health resources that are also HIV-competent are scarce throughout the city, and older adults with HIV are among the least likely to be referred to mental health support.

What Accountability Looks Like

Addressing this crisis requires action on multiple fronts simultaneously. Medical education must more explicitly address HIV risk across the lifespan, dismantling the age-bound assumptions embedded in clinical training. Continuing medical education programs—particularly those targeting primary care internists and geriatricians—should include updated, evidence-based modules on HIV screening in older adults.

Health systems must also take institutional responsibility for the gap. Routine HIV screening prompts embedded in electronic health records, applied universally rather than filtered by assumed risk profiles, have demonstrated effectiveness in increasing testing rates. New York City's public hospital system, which serves a large proportion of older low-income New Yorkers, is positioned to model this kind of structural intervention.

Community-based organizations working with older New Yorkers—senior centers, faith institutions, housing programs—have a complementary role to play in reducing the stigma that keeps older adults from initiating the conversation with their providers. Culturally specific outreach that speaks directly to the experiences of older Black, Latino, and immigrant New Yorkers has proven effective in other public health contexts and can be deployed here.

The Years That Cannot Be Returned

For Margaret, the diagnosis came in time for treatment to stabilize her health. She is now virally suppressed and engaged with an HIV care team that understands the intersection of aging and HIV management. But she is clear-eyed about what the delay cost her—in health, in peace of mind, and in the years during which she unknowingly placed a partner at risk.

"Nobody ever asked me," she said. "Not once, in all those years of appointments. Nobody ever thought it could be me."

That assumption—that HIV could not possibly be this patient, this age, this life—is the assumption New York's medical community must urgently interrogate. The epidemic did not stop at a certain birthday. Neither should the care.